Cerebras SystemsCBRS announced on Thursday (July 22) that it has inked a partnership with CrowdStrikeCRWD, under which the latter will leverage CBRS’ wafer-scale inference technology to help power Falcon AI Detection and Response (AIDR). This will enable larger AI security models to operate at machine speed for real-time threat detection. At the same time, Cerebras has standardized on the CrowdStrike Falcon platform to secure its own operations, underscoring the strategic nature of the collaboration.
Cerebras’ latest partnership with CrowdStrike marks another important validation of its high-speed AI inference platform and expands its presence into one of the fastest-growing enterprise AI markets — cybersecurity. The partnership reinforces Cerebras’ strategy of targeting latency-sensitive AI inference workloads, where response time directly impacts business outcomes. The company has emphasized that “fast tokens are more valuable tokens” because speed improves productivity and enables new AI applications, which are necessary for cybersecurity applications.
The CrowdStrike collaboration broadens Cerebras’ customer base beyond frontier AI model developers into enterprise software. This diversification complements the company’s recently announced multi-year OpenAI agreement worth more than $20 billion and its Amazon Web Services partnership, which are already driving strong commercial momentum. In the first quarter of 2026, revenues increased 94% year over year to $193.4 million, including 178% growth in cloud and other services revenues, reflecting accelerating adoption of Cerebras’ inference platform. CBRS raised its 2026 core revenue guidance to $855-$865 million, indicating 69% year-over-year growth at the midpoint.
The CrowdStrike partnership strengthens Cerebras’ positioning as an enterprise AI infrastructure provider rather than solely a hardware vendor. Cloud and services revenues are becoming an increasingly important growth driver for the company. Remaining performance obligations reached approximately $25 billion at the end of first-quarter, largely supported by long-term AI infrastructure contracts. The addition of cybersecurity to CBRS’ portfolio of inference use cases expands the company’s addressable market, thereby driving top-line growth over the long term.
Cerebras Faces Tough Competition
Cerebras is facing stiff competition from the likes of CoreWeaveCRWV and BroadcomAVGO in the AI infrastructure domain.
CoreWeave is pursuing one of the industry's largest AI infrastructure expansions. In partnership with NVIDIA, the company plans to build more than 5 gigawatts (GW) of AI factory capacity by 2030 while adopting multiple generations of NVIDIA AI platforms. It also recently expanded its European footprint through new AI cloud deployments in Stockholm, Sweden, powered by renewable energy, and signed a $21 billion long-term AI infrastructure agreement with Meta.
Broadcom has been benefiting from rising AI revenues, driven by strong demand for XPUs. AI semiconductor revenues reached a record $10.8 billion in the fiscal second quarter, suggesting a 143% year-over-year surge. Broadcom expects it to rise to $16 billion in the fiscal third quarter, indicating more than 200% year-over-year growth. AVGO’s management disclosed that AI semiconductor bookings exceeded $30 billion during the fiscal second quarter, nearly three times quarterly AI shipments. Remaining Performance Obligations reached $164.6 billion, including commitments under new custom AI accelerator contracts. These agreements provide exceptional long-term revenue visibility.
Zacks' Research Chief Names "Stock Most Likely to Double"
Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.
This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article.
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.